The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1

ABSTRACT The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) ha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of bone and mineral research 2017-10, Vol.32 (10), p.2103-2115
Hauptverfasser: McMichael, Brooke K, Jeong, Yong‐Hoon, Auerbach, Justin A, Han, Cheol‐Min, Sedlar, Ryan, Shettigar, Vikram, Bähler, Martin, Agarwal, Sudha, Kim, Do‐Gyoon, Lee, Beth S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2115
container_issue 10
container_start_page 2103
container_title Journal of bone and mineral research
container_volume 32
creator McMichael, Brooke K
Jeong, Yong‐Hoon
Auerbach, Justin A
Han, Cheol‐Min
Sedlar, Ryan
Shettigar, Vikram
Bähler, Martin
Agarwal, Sudha
Kim, Do‐Gyoon
Lee, Beth S
description ABSTRACT The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) have been linked to poor bone health in humans and mice, but the effects of RhoA‐specific GTPase‐activating proteins (GAPs) on bone quality have not yet been identified. Therefore, we examined the consequences of RhoGAP Myo9b gene knockout on bone growth, phenotype, and cellular activity. Male and female mice lacking both alleles demonstrated growth retardation and decreased bone formation rates during early puberty. These mice had smaller, weaker bones by 4 weeks of age, but only female KOs had altered cellular numbers, with fewer osteoblasts and more osteoclasts. By 12 weeks of age, bone quality in KOs worsened. In contrast, 4‐week‐old heterozygotes demonstrated bone defects that resolved by 12 weeks of age. Throughout, Myo9b ablation affected females more than males. Osteoclast activity appeared unaffected. In primary osteogenic cells, Myo9b was distributed in stress fibers and focal adhesions, and its absence resulted in poor spreading and eventual detachment from culture dishes. Similarly, MC3T3‐E1 preosteoblasts with transiently suppressed Myo9b levels spread poorly and contained decreased numbers of focal adhesions. These cells also demonstrated reduced ability to undergo IGF‐1–induced spreading or chemotaxis toward IGF‐1, though responses to PDGF and BMP‐2 were unaffected. IGF‐1 receptor (IGF1R) activation was normal in cells with diminished Myo9b levels, but the activated receptor was redistributed from stress fibers and focal adhesions into nuclei, potentially affecting receptor accessibility and gene expression. These results demonstrate that Myo9b regulates a subset of RhoA‐activated processes necessary for IGF‐1 responsiveness in osteogenic cells, and is critical for normal bone formation in growing mice. © 2017 American Society for Bone and Mineral Research
doi_str_mv 10.1002/jbmr.3192
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1906466743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1950412972</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3882-25ae17c33a08f51000b7510dbcf6f8b9cee00fb89ffe30f5d3d1aceb7d255193</originalsourceid><addsrcrecordid>eNp10L1OwzAUBWALgWgpDLwAssQCQ1r_xI4zAoJSREVVdWGK4uSapkriYqegbjwCz8iTkFJgQGI6y6ejew9Cx5T0KSFssNCV63Masx3UpYLxIJSK7qIuUSoMSMhpBx14vyCESCHlPuowJZSQseiix9kc8HRuhxcTPF7bWOOJs5VtwONLWwMeOvvazLFe4zHkRdoU9RN-8A1YXaa-KTI8Bb-0tS9eoAbvcWPxaHjz8fZOD9GeSUsPR9_ZQ7Ob69nVbXD_MBxdXdwHGVeKBUykQKOM85QoI9p3iI7ayHVmpFE6zgAIMVrFxgAnRuQ8p2kGOsqZEDTmPXS2rV06-7wC3yRV4TMoy7QGu_IJjYkMpYxC3tLTP3RhV65uj2uVICFlccRadb5VmbPeOzDJ0hVV6tYJJclm7mQzd7KZu7Un340rXUH-K3_2bcFgC16LEtb_NyV3l-PpV-Un7LKJug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1950412972</pqid></control><display><type>article</type><title>The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>McMichael, Brooke K ; Jeong, Yong‐Hoon ; Auerbach, Justin A ; Han, Cheol‐Min ; Sedlar, Ryan ; Shettigar, Vikram ; Bähler, Martin ; Agarwal, Sudha ; Kim, Do‐Gyoon ; Lee, Beth S</creator><creatorcontrib>McMichael, Brooke K ; Jeong, Yong‐Hoon ; Auerbach, Justin A ; Han, Cheol‐Min ; Sedlar, Ryan ; Shettigar, Vikram ; Bähler, Martin ; Agarwal, Sudha ; Kim, Do‐Gyoon ; Lee, Beth S</creatorcontrib><description>ABSTRACT The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) have been linked to poor bone health in humans and mice, but the effects of RhoA‐specific GTPase‐activating proteins (GAPs) on bone quality have not yet been identified. Therefore, we examined the consequences of RhoGAP Myo9b gene knockout on bone growth, phenotype, and cellular activity. Male and female mice lacking both alleles demonstrated growth retardation and decreased bone formation rates during early puberty. These mice had smaller, weaker bones by 4 weeks of age, but only female KOs had altered cellular numbers, with fewer osteoblasts and more osteoclasts. By 12 weeks of age, bone quality in KOs worsened. In contrast, 4‐week‐old heterozygotes demonstrated bone defects that resolved by 12 weeks of age. Throughout, Myo9b ablation affected females more than males. Osteoclast activity appeared unaffected. In primary osteogenic cells, Myo9b was distributed in stress fibers and focal adhesions, and its absence resulted in poor spreading and eventual detachment from culture dishes. Similarly, MC3T3‐E1 preosteoblasts with transiently suppressed Myo9b levels spread poorly and contained decreased numbers of focal adhesions. These cells also demonstrated reduced ability to undergo IGF‐1–induced spreading or chemotaxis toward IGF‐1, though responses to PDGF and BMP‐2 were unaffected. IGF‐1 receptor (IGF1R) activation was normal in cells with diminished Myo9b levels, but the activated receptor was redistributed from stress fibers and focal adhesions into nuclei, potentially affecting receptor accessibility and gene expression. These results demonstrate that Myo9b regulates a subset of RhoA‐activated processes necessary for IGF‐1 responsiveness in osteogenic cells, and is critical for normal bone formation in growing mice. © 2017 American Society for Bone and Mineral Research</description><identifier>ISSN: 0884-0431</identifier><identifier>EISSN: 1523-4681</identifier><identifier>DOI: 10.1002/jbmr.3192</identifier><identifier>PMID: 28585695</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Actin ; Age ; Animals ; Biomechanical Phenomena ; Bone Development - drug effects ; Bone growth ; Bone morphogenetic protein 2 ; BONE QCT/μCT ; Cancellous Bone - metabolism ; Cancellous Bone - pathology ; Cancellous Bone - physiopathology ; Cell Adhesion ; Cell culture ; Cell Line ; Cell migration ; Chemotaxis ; Females ; Femur - metabolism ; Femur - pathology ; Femur - physiopathology ; Fibers ; Gene expression ; Gene Knockdown Techniques ; GH/IGF‐1 ; Growth rate ; Guanine ; Guanosine ; Guanosine triphosphatases ; Heterozygotes ; Insulin-like growth factor I ; Insulin-Like Growth Factor I - pharmacology ; Mechanotransduction ; Mice, Inbred C57BL ; Mice, Knockout ; MOLECULAR PATHWAYS–DEVELOPMENT ; Myosins - deficiency ; Myosins - metabolism ; Nuclei ; OSTEOBLASTS ; Osteoblasts - drug effects ; Osteoblasts - metabolism ; Osteoclasts ; Osteogenesis ; OSTEOPOROSIS ; Platelet-derived growth factor ; Puberty ; Rats ; Sexual Maturation</subject><ispartof>Journal of bone and mineral research, 2017-10, Vol.32 (10), p.2103-2115</ispartof><rights>2017 American Society for Bone and Mineral Research</rights><rights>2017 American Society for Bone and Mineral Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3882-25ae17c33a08f51000b7510dbcf6f8b9cee00fb89ffe30f5d3d1aceb7d255193</citedby><cites>FETCH-LOGICAL-c3882-25ae17c33a08f51000b7510dbcf6f8b9cee00fb89ffe30f5d3d1aceb7d255193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjbmr.3192$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjbmr.3192$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28585695$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McMichael, Brooke K</creatorcontrib><creatorcontrib>Jeong, Yong‐Hoon</creatorcontrib><creatorcontrib>Auerbach, Justin A</creatorcontrib><creatorcontrib>Han, Cheol‐Min</creatorcontrib><creatorcontrib>Sedlar, Ryan</creatorcontrib><creatorcontrib>Shettigar, Vikram</creatorcontrib><creatorcontrib>Bähler, Martin</creatorcontrib><creatorcontrib>Agarwal, Sudha</creatorcontrib><creatorcontrib>Kim, Do‐Gyoon</creatorcontrib><creatorcontrib>Lee, Beth S</creatorcontrib><title>The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1</title><title>Journal of bone and mineral research</title><addtitle>J Bone Miner Res</addtitle><description>ABSTRACT The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) have been linked to poor bone health in humans and mice, but the effects of RhoA‐specific GTPase‐activating proteins (GAPs) on bone quality have not yet been identified. Therefore, we examined the consequences of RhoGAP Myo9b gene knockout on bone growth, phenotype, and cellular activity. Male and female mice lacking both alleles demonstrated growth retardation and decreased bone formation rates during early puberty. These mice had smaller, weaker bones by 4 weeks of age, but only female KOs had altered cellular numbers, with fewer osteoblasts and more osteoclasts. By 12 weeks of age, bone quality in KOs worsened. In contrast, 4‐week‐old heterozygotes demonstrated bone defects that resolved by 12 weeks of age. Throughout, Myo9b ablation affected females more than males. Osteoclast activity appeared unaffected. In primary osteogenic cells, Myo9b was distributed in stress fibers and focal adhesions, and its absence resulted in poor spreading and eventual detachment from culture dishes. Similarly, MC3T3‐E1 preosteoblasts with transiently suppressed Myo9b levels spread poorly and contained decreased numbers of focal adhesions. These cells also demonstrated reduced ability to undergo IGF‐1–induced spreading or chemotaxis toward IGF‐1, though responses to PDGF and BMP‐2 were unaffected. IGF‐1 receptor (IGF1R) activation was normal in cells with diminished Myo9b levels, but the activated receptor was redistributed from stress fibers and focal adhesions into nuclei, potentially affecting receptor accessibility and gene expression. These results demonstrate that Myo9b regulates a subset of RhoA‐activated processes necessary for IGF‐1 responsiveness in osteogenic cells, and is critical for normal bone formation in growing mice. © 2017 American Society for Bone and Mineral Research</description><subject>Actin</subject><subject>Age</subject><subject>Animals</subject><subject>Biomechanical Phenomena</subject><subject>Bone Development - drug effects</subject><subject>Bone growth</subject><subject>Bone morphogenetic protein 2</subject><subject>BONE QCT/μCT</subject><subject>Cancellous Bone - metabolism</subject><subject>Cancellous Bone - pathology</subject><subject>Cancellous Bone - physiopathology</subject><subject>Cell Adhesion</subject><subject>Cell culture</subject><subject>Cell Line</subject><subject>Cell migration</subject><subject>Chemotaxis</subject><subject>Females</subject><subject>Femur - metabolism</subject><subject>Femur - pathology</subject><subject>Femur - physiopathology</subject><subject>Fibers</subject><subject>Gene expression</subject><subject>Gene Knockdown Techniques</subject><subject>GH/IGF‐1</subject><subject>Growth rate</subject><subject>Guanine</subject><subject>Guanosine</subject><subject>Guanosine triphosphatases</subject><subject>Heterozygotes</subject><subject>Insulin-like growth factor I</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>Mechanotransduction</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>MOLECULAR PATHWAYS–DEVELOPMENT</subject><subject>Myosins - deficiency</subject><subject>Myosins - metabolism</subject><subject>Nuclei</subject><subject>OSTEOBLASTS</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoblasts - metabolism</subject><subject>Osteoclasts</subject><subject>Osteogenesis</subject><subject>OSTEOPOROSIS</subject><subject>Platelet-derived growth factor</subject><subject>Puberty</subject><subject>Rats</subject><subject>Sexual Maturation</subject><issn>0884-0431</issn><issn>1523-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10L1OwzAUBWALgWgpDLwAssQCQ1r_xI4zAoJSREVVdWGK4uSapkriYqegbjwCz8iTkFJgQGI6y6ejew9Cx5T0KSFssNCV63Masx3UpYLxIJSK7qIuUSoMSMhpBx14vyCESCHlPuowJZSQseiix9kc8HRuhxcTPF7bWOOJs5VtwONLWwMeOvvazLFe4zHkRdoU9RN-8A1YXaa-KTI8Bb-0tS9eoAbvcWPxaHjz8fZOD9GeSUsPR9_ZQ7Ob69nVbXD_MBxdXdwHGVeKBUykQKOM85QoI9p3iI7ayHVmpFE6zgAIMVrFxgAnRuQ8p2kGOsqZEDTmPXS2rV06-7wC3yRV4TMoy7QGu_IJjYkMpYxC3tLTP3RhV65uj2uVICFlccRadb5VmbPeOzDJ0hVV6tYJJclm7mQzd7KZu7Un340rXUH-K3_2bcFgC16LEtb_NyV3l-PpV-Un7LKJug</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>McMichael, Brooke K</creator><creator>Jeong, Yong‐Hoon</creator><creator>Auerbach, Justin A</creator><creator>Han, Cheol‐Min</creator><creator>Sedlar, Ryan</creator><creator>Shettigar, Vikram</creator><creator>Bähler, Martin</creator><creator>Agarwal, Sudha</creator><creator>Kim, Do‐Gyoon</creator><creator>Lee, Beth S</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201710</creationdate><title>The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1</title><author>McMichael, Brooke K ; Jeong, Yong‐Hoon ; Auerbach, Justin A ; Han, Cheol‐Min ; Sedlar, Ryan ; Shettigar, Vikram ; Bähler, Martin ; Agarwal, Sudha ; Kim, Do‐Gyoon ; Lee, Beth S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3882-25ae17c33a08f51000b7510dbcf6f8b9cee00fb89ffe30f5d3d1aceb7d255193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Actin</topic><topic>Age</topic><topic>Animals</topic><topic>Biomechanical Phenomena</topic><topic>Bone Development - drug effects</topic><topic>Bone growth</topic><topic>Bone morphogenetic protein 2</topic><topic>BONE QCT/μCT</topic><topic>Cancellous Bone - metabolism</topic><topic>Cancellous Bone - pathology</topic><topic>Cancellous Bone - physiopathology</topic><topic>Cell Adhesion</topic><topic>Cell culture</topic><topic>Cell Line</topic><topic>Cell migration</topic><topic>Chemotaxis</topic><topic>Females</topic><topic>Femur - metabolism</topic><topic>Femur - pathology</topic><topic>Femur - physiopathology</topic><topic>Fibers</topic><topic>Gene expression</topic><topic>Gene Knockdown Techniques</topic><topic>GH/IGF‐1</topic><topic>Growth rate</topic><topic>Guanine</topic><topic>Guanosine</topic><topic>Guanosine triphosphatases</topic><topic>Heterozygotes</topic><topic>Insulin-like growth factor I</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>Mechanotransduction</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>MOLECULAR PATHWAYS–DEVELOPMENT</topic><topic>Myosins - deficiency</topic><topic>Myosins - metabolism</topic><topic>Nuclei</topic><topic>OSTEOBLASTS</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoblasts - metabolism</topic><topic>Osteoclasts</topic><topic>Osteogenesis</topic><topic>OSTEOPOROSIS</topic><topic>Platelet-derived growth factor</topic><topic>Puberty</topic><topic>Rats</topic><topic>Sexual Maturation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McMichael, Brooke K</creatorcontrib><creatorcontrib>Jeong, Yong‐Hoon</creatorcontrib><creatorcontrib>Auerbach, Justin A</creatorcontrib><creatorcontrib>Han, Cheol‐Min</creatorcontrib><creatorcontrib>Sedlar, Ryan</creatorcontrib><creatorcontrib>Shettigar, Vikram</creatorcontrib><creatorcontrib>Bähler, Martin</creatorcontrib><creatorcontrib>Agarwal, Sudha</creatorcontrib><creatorcontrib>Kim, Do‐Gyoon</creatorcontrib><creatorcontrib>Lee, Beth S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and mineral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McMichael, Brooke K</au><au>Jeong, Yong‐Hoon</au><au>Auerbach, Justin A</au><au>Han, Cheol‐Min</au><au>Sedlar, Ryan</au><au>Shettigar, Vikram</au><au>Bähler, Martin</au><au>Agarwal, Sudha</au><au>Kim, Do‐Gyoon</au><au>Lee, Beth S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1</atitle><jtitle>Journal of bone and mineral research</jtitle><addtitle>J Bone Miner Res</addtitle><date>2017-10</date><risdate>2017</risdate><volume>32</volume><issue>10</issue><spage>2103</spage><epage>2115</epage><pages>2103-2115</pages><issn>0884-0431</issn><eissn>1523-4681</eissn><abstract>ABSTRACT The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) have been linked to poor bone health in humans and mice, but the effects of RhoA‐specific GTPase‐activating proteins (GAPs) on bone quality have not yet been identified. Therefore, we examined the consequences of RhoGAP Myo9b gene knockout on bone growth, phenotype, and cellular activity. Male and female mice lacking both alleles demonstrated growth retardation and decreased bone formation rates during early puberty. These mice had smaller, weaker bones by 4 weeks of age, but only female KOs had altered cellular numbers, with fewer osteoblasts and more osteoclasts. By 12 weeks of age, bone quality in KOs worsened. In contrast, 4‐week‐old heterozygotes demonstrated bone defects that resolved by 12 weeks of age. Throughout, Myo9b ablation affected females more than males. Osteoclast activity appeared unaffected. In primary osteogenic cells, Myo9b was distributed in stress fibers and focal adhesions, and its absence resulted in poor spreading and eventual detachment from culture dishes. Similarly, MC3T3‐E1 preosteoblasts with transiently suppressed Myo9b levels spread poorly and contained decreased numbers of focal adhesions. These cells also demonstrated reduced ability to undergo IGF‐1–induced spreading or chemotaxis toward IGF‐1, though responses to PDGF and BMP‐2 were unaffected. IGF‐1 receptor (IGF1R) activation was normal in cells with diminished Myo9b levels, but the activated receptor was redistributed from stress fibers and focal adhesions into nuclei, potentially affecting receptor accessibility and gene expression. These results demonstrate that Myo9b regulates a subset of RhoA‐activated processes necessary for IGF‐1 responsiveness in osteogenic cells, and is critical for normal bone formation in growing mice. © 2017 American Society for Bone and Mineral Research</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28585695</pmid><doi>10.1002/jbmr.3192</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0884-0431
ispartof Journal of bone and mineral research, 2017-10, Vol.32 (10), p.2103-2115
issn 0884-0431
1523-4681
language eng
recordid cdi_proquest_miscellaneous_1906466743
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Oxford University Press Journals All Titles (1996-Current)
subjects Actin
Age
Animals
Biomechanical Phenomena
Bone Development - drug effects
Bone growth
Bone morphogenetic protein 2
BONE QCT/μCT
Cancellous Bone - metabolism
Cancellous Bone - pathology
Cancellous Bone - physiopathology
Cell Adhesion
Cell culture
Cell Line
Cell migration
Chemotaxis
Females
Femur - metabolism
Femur - pathology
Femur - physiopathology
Fibers
Gene expression
Gene Knockdown Techniques
GH/IGF‐1
Growth rate
Guanine
Guanosine
Guanosine triphosphatases
Heterozygotes
Insulin-like growth factor I
Insulin-Like Growth Factor I - pharmacology
Mechanotransduction
Mice, Inbred C57BL
Mice, Knockout
MOLECULAR PATHWAYS–DEVELOPMENT
Myosins - deficiency
Myosins - metabolism
Nuclei
OSTEOBLASTS
Osteoblasts - drug effects
Osteoblasts - metabolism
Osteoclasts
Osteogenesis
OSTEOPOROSIS
Platelet-derived growth factor
Puberty
Rats
Sexual Maturation
title The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T03%3A04%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20RhoGAP%20Myo9b%20Promotes%20Bone%20Growth%20by%20Mediating%20Osteoblastic%20Responsiveness%20to%20IGF%E2%80%901&rft.jtitle=Journal%20of%20bone%20and%20mineral%20research&rft.au=McMichael,%20Brooke%20K&rft.date=2017-10&rft.volume=32&rft.issue=10&rft.spage=2103&rft.epage=2115&rft.pages=2103-2115&rft.issn=0884-0431&rft.eissn=1523-4681&rft_id=info:doi/10.1002/jbmr.3192&rft_dat=%3Cproquest_cross%3E1950412972%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1950412972&rft_id=info:pmid/28585695&rfr_iscdi=true